- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2011
- Public Summary Document (PSD) July 2011 PBAC Meeting - PDF
Dasatinib – July 2011
Dasatinib, tablets, 20 mg, 50 mg, 70 mg and 100 mg, Sprycel® - July 2011
Last updated
28 October 2011